Patents by Inventor Jeremy Kintigh

Jeremy Kintigh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TTPO (5 6,7-trithiapentacene-13-one) and its derivatives: a new class of thermally stable, photooxidatively resistant organic semiconductors
    Patent number: 8389744
    Abstract: The present invention is directed towards a new class of semi-conducting acene derivatives. These compounds are soluble species and they all possess superior thermal stability and photooxidative resistance as compared to their counterparts that lack the substitution patterns disclosed herein.
    Type: Grant
    Filed: October 11, 2011
    Date of Patent: March 5, 2013
    Assignee: University of New Hampshire
    Inventors: Glen P. Miller, Jeremy Kintigh
  • Pyrrolidinone derivatives
    Patent number: 6936633
    Abstract: The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.
    Type: Grant
    Filed: December 31, 2003
    Date of Patent: August 30, 2005
    Assignee: UCB S.A.
    Inventors: Dong Zou, Olivier Dasse, Janelle Evans, Paul Higgins, Jeremy Kintigh, Rama Kondru, Eric Schwartz, Laurent Knerr, Hai-Xiao Zhai
  • Pyrrolidinone derivatives
    Publication number: 20050004180
    Abstract: The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.
    Type: Application
    Filed: September 26, 2002
    Publication date: January 6, 2005
    Inventors: Dong Zou, Olivier Dasse, Janelle Evans, Paul Higgins, Jeremy Kintigh, Laurent Knerr, Rama Kondru, Eric Schwartz, Hai-Xiao Zhai
  • Pyrrolidinone derivatives
    Publication number: 20040157914
    Abstract: The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.
    Type: Application
    Filed: December 31, 2003
    Publication date: August 12, 2004
    Applicant: UCB, S.A.
    Inventors: Dong Zou, Olivier Dasse, Janelle Evans, Paul Higgins, Jeremy Kintigh, Rama Kondru, Eric Schwartz, Laurent Knerr, Hai-Xiao Zhai
  • Pyrrolidinone derivatives
    Patent number: 6727275
    Abstract: The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: April 27, 2004
    Assignee: UCB, S.A./N.V.
    Inventors: Dong Zou, Olivier Dasse, Janelle Evans, Paul Higgins, Jeremy Kintigh, Rama Kondru, Eric Schwartz, Laurent Knerr, Hai-Xiao Zhai
  • Pyrrolidinone derivatives
    Publication number: 20030149081
    Abstract: The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.
    Type: Application
    Filed: September 26, 2002
    Publication date: August 7, 2003
    Inventors: Dong Zou, Olivier Dasse, Janelle Evans, Paul Higgins, Jeremy Kintigh, Rama Kondru, Eric Schwartz, Laurent Knerr, Hai-Xiao Zhai